Press release
Immunoassay Market worth $41.57 billion by 2030 | Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Exclusive Report by 360iResearch
Immunoassay Market | 360iResearch
Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/immunoassay?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immunoassay Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Market Segmentation & Coverage:
This research report categorizes the Global Immunoassay Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Analyzer and Consumables. The Consumables is projected to witness significant market share during forecast period.
Based on Technology, market is studied across Chemiluminescence Immunoassay, Enzyme-linked Fluorescence Assay, Enzyme-linked Immunosorbent Assay, and Radioimmunoassay. The Chemiluminescence Immunoassay is projected to witness significant market share during forecast period.
Based on Application, market is studied across Cardiology, Endocrinology, Infectious Disease, Oncology, and Orthopedics. The Infectious Disease is projected to witness significant market share during forecast period.
Based on End User, market is studied across Blood Banks, Diagnostics Laboratories, and Hospitals. The Diagnostics Laboratories is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Global Immunoassay Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Immunoassay Market, including Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Epitope Diagnostics Inc., F. Hoffmann-La Roche Ltd., Gyros Protein Technologies AB, J. Mitra & Co. Pvt. Ltd., Kamiya Biomedical Company, Merck KGaA, Ortho-Clinical Diagnostics, Inc., Quidel Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and WAK-Chemie Medical GmbH.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Immunoassay Market, by Product
7. Immunoassay Market, by Technology
8. Immunoassay Market, by Application
9. Immunoassay Market, by End User
10. Americas Immunoassay Market
11. Asia-Pacific Immunoassay Market
12. Europe, Middle East & Africa Immunoassay Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Immunoassay Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunoassay Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunoassay Market?
4. What is the competitive strategic window for opportunities in the Global Immunoassay Market?
5. What are the technology trends and regulatory frameworks in the Global Immunoassay Market?
6. What is the market share of the leading vendors in the Global Immunoassay Market?
7. What modes and strategic moves are considered suitable for entering the Global Immunoassay Market?
Read More @ https://www.360iresearch.com/library/intelligence/immunoassay?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoassay Market worth $41.57 billion by 2030 | Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Exclusive Report by 360iResearch here
News-ID: 3221335 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Immunoassay
Prominent Chemiluminescence Immunoassay Analyzer Market Trend for 2025: Innovati …
What combination of drivers is leading to accelerated growth in the chemiluminescence immunoassay analyzer market?
The increasing incidence of chronic illnesses is predicted to spur the expansion of the chemiluminescence immunoassay analyzer market. Factors like aging populations, unhealthy lifestyles, and advancements in healthcare which prolong the lifespan of individuals with severe conditions, contribute to the rise in chronic diseases. Chemiluminescence immunoassay analyzers play a crucial role in managing chronic illnesses by…
Global Bench-top Automated Immunoassay Analyzer Market Size - By Product Type(Ch …
Bench-top Automated Immunoassay Analyzer Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Bench-top Automated Immunoassay Analyzer Market Scope: Unveiling Today's Trends
A Bench-top Automated Immunoassay Analyzer is a compact device used for conducting immunoassays in laboratory settings, enhancing efficiency and accuracy. The market for these analyzers is experiencing significant growth driven by rising demand for rapid diagnostic testing and advancements in technology. Increased prevalence of conditions such as infectious diseases and…
Immunoassay Market - Advancing Patient Care through Immunoassay Solutions
Newark, New Castle, USA: The "Immunoassay Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Immunoassay Market: https://www.growthplusreports.com/report/immunoassay-market/8429
This latest report researches the industry structure, sales, revenue, price and…
Bahrain Immunoassay Analyzer Market
Transparent healthcare framework & strict procurement system enables the authorities in gaining the trust of the end-users leading to the growth of the medical devices industry in Bahrain: Ken Research
Heavy Government involvement in the industry: Bahrain has been maintaining a basic framework for a transparent, rules-based government procurement system. Bahrain hospitals and clinics, as well as developing specialist treatments, are continuously growing. This has improved the installation of BGA, POC…
Immunoassay Market Competitive Dynamics 2027
According to the new research report published by The Insight Partners, titled "Immunoassay Market- Global Analysis and Forecast to 2027".
The global immunoassay market is US$ 21,800.0 Mn in 2018 and is predicted to grow at a CAGR of 6.5% during the forecast period 2019 - 2027, to reach US$ 37,987.8 Mn by 2027.
Immunoassay Market Report presents a competitive scenario of key Immunoassay Industry players with their market share, sales, revenue…
Immunoassay Market: Opportunities and Challenges
The Immunoassay Market is expected to reach 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436
Will the development of condition-specific biomarkers and tests create opportunities for growth for players in the immunoassay market?
Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases.…
